Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/177231
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Vaquerizo, Beatriz | - |
dc.contributor.author | Miranda-Guardiola, Faustino | - |
dc.contributor.author | Fernández, Eduardo | - |
dc.contributor.author | Rumoroso, José Ramón | - |
dc.contributor.author | Gómez Hospital, Josep Antoni | - |
dc.contributor.author | Bossa, Francisco | - |
dc.contributor.author | Iñiguez Romo, Andres | - |
dc.contributor.author | Oategui, Imanol | - |
dc.contributor.author | Serra, Antonio | - |
dc.date.accessioned | 2021-05-13T12:45:31Z | - |
dc.date.available | 2021-05-13T12:45:31Z | - |
dc.date.issued | 2015-10-01 | - |
dc.identifier.issn | 0896-4327 | - |
dc.identifier.uri | http://hdl.handle.net/2445/177231 | - |
dc.description.abstract | Background: small vessel disease (SMD) remains a major challenge because of the increased risk of restenosis. We sought to assess the efficacy and safety of a paclitaxel-eluting balloon (PEB) in patients with SMD. Methods and results: one-hundred and four patients with native coronary lesions in small vessels treated by using a PEB were included in this prospective multicenter registry. In each case, after regular balloon dilatation, a larger PEB was inflated for a minimum of 45-60 seconds. Patients were 65 ± 10 years old, 43% diabetic, and 58% presented acutely. Angiographic success was 93% (7% bailout BMS implantation due to coronary dissection). The rate of major adverse cardiac events (MACE) at 12 months was 4.8% (1.9% cardiac death, 1.0% MI, and 2.9% TLR). One definite stent thrombosis was reported at 6 months in a patient with bailout BMS implantation. At 7 months, late loss was 0.31 ± 0.2 mm. Bail-out BMS after DEB use, was an independent predictor of MACE, HR 18.74, 95%CI (2.58-135.84) and TLR, HR 30.99, 95%CI (2.79-344.07). Conclusion: the use of this PEB for the treatment of SMD provides excellent 1-year outcomes with only 4.8% MACE. The need for a bailout BMS was a strong predictor of MACE and TLR. | - |
dc.format.extent | 9 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | Wiley Hindawi Publishing | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.1111/joic.12227 | - |
dc.relation.ispartof | Journal of Interventional Cardiology, 2015, vol. 28, num. 5, p. 430-438 | - |
dc.relation.uri | https://doi.org/10.1111/joic.12227 | - |
dc.rights | cc-by (c) Vaquerizo, Beatriz et al., 2015 | - |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | - |
dc.source | Articles publicats en revistes (Ciències Clíniques) | - |
dc.subject.classification | Efectes secundaris dels medicaments | - |
dc.subject.classification | Malalties coronàries | - |
dc.subject.classification | Pròtesis de Stent | - |
dc.subject.classification | Ús terapèutic | - |
dc.subject.other | Drug side effects | - |
dc.subject.other | Coronary diseases | - |
dc.subject.other | Stents (Surgery) | - |
dc.subject.other | Therapeutic use | - |
dc.title | Treatment of small vessel disease with the paclitaxel drug-eluting balloon: 6-month angiographic and 1-year clinical outcomes of the Spanish multicenter registry | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.identifier.idgrec | 695960 | - |
dc.date.updated | 2021-05-13T12:45:31Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 26381619 | - |
Appears in Collections: | Articles publicats en revistes (Ciències Clíniques) Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
695960.pdf | 881 kB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License